← Back to Vaccine Database

CMV gB

Protein based vaccine · VDDBV0159

Target & Classification

CMVCytomegalovirus
Protein based vaccine
Cytomegalovirus Infections
Phase 2

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials2

NCT IDPhaseDisease / Condition
NCT00125502 Phase 2Cytomegalovirus Infections
NCT00299260 Phase 2Cytomegalovirus Infections